Methyl-.beta.-orcinolcarboxylate from lichen (everniastrum...

Details Methyl-.beta.-orcinolcarboxylate from lichen (everniastrum... Methyl-.beta.-orcinolcarboxylate from lichen (everniastrum...

A - Human Necessities

61

K

A61K 31/235 (2006.01) A61K 36/09 (2006.01) A61P 31/10 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2521055

The present invention relates to the new use of an already known biomolecule methyl-.beta.-orcinol carboxylate of formula (I) isolated from a lichen (Everniastrum cirrhatum), for treating pathogenic fungal infections of humans that are resistant to polyene and azole antibiotics such as amphotericin B, nystatin, clotrimazole etc.

La présente invention concerne une nouvelle utilisation de la biomolécule de méthyl-.beta.-orcinol-carboxylate déjà connue, représentée par la formule (I), et isolée d'un lichen (Everniastrum cirrhatum). Cette nouvelle utilisation vise au traitement d'infections fongiques pathogènes chez les humains résistantes aux antibiotiques polyèniques et azoliques tels que notamment l'amphotéricine B, la nystatine, le clotrimazole.

Affiliated with

Also associated with

Rating

Methyl-.beta.-orcinolcarboxylate from lichen (everniastrum... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methyl-.beta.-orcinolcarboxylate from lichen (everniastrum..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methyl-.beta.-orcinolcarboxylate from lichen (everniastrum... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1566736